October 10, 2023 01:25 PM EDTUpdated February 29, 12:13 PM
Manufacturing

Eu­roAPI stock craters af­ter slow CD­MO, API busi­ness slash­es 2023 sales fore­cast

Anna Brown

News Reporter

Eu­roAPI saw its stock plum­met by near­ly 60% on Tues­day af­ter it an­nounced it is cut­ting its 2023 sales growth pre­dic­tions. The down­turn was blamed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times